Unfortunately, the majority of EGFR-mutant NSCLC patients that show an initial radiological response to EGFR-TKIs, eventually progress and their tumors develop different mechanisms of resistance [12]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.